Literature DB >> 3201974

Growth in children treated for acute lymphoblastic leukemia with and without prophylactic cranial irradiation.

C Moëll1, S Garwicz, I Marky, L Mellander, J Karlberg.   

Abstract

Growth and weight gain were studied longitudinally over a period of four years in thirty-nine children treated for acute lymphoblastic leukemia. The children were divided into two groups according to treatment. Twenty-eight children were given prophylactic cranial irradiation and eleven children were treated without such irradiation. The duration of cytostatic treatment was three years in all cases. Average growth during the first two years was similar in the two groups, and the standard deviation scores (SDS) were below average. The rate of growth (in height) during the fourth year was significantly higher among those children who had not received cranial irradiation (p less than 0.01). After four years the average attained height had declined 0.5 SD for children treated with cranial irradiation and 0.2 SD for children without such treatment. Weight velocity was significantly greater than the expected mean in the non-irradiated group during the first year and in the irradiated group during the fourth year of the study. Attained weight after four years had increased 0.4 SD more among those children who had not received irradiation. The results suggest that prophylactic cranial irradiation is responsible for the greater part of the prepubertal growth inhibition in these children.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3201974     DOI: 10.1111/j.1651-2227.1988.tb10731.x

Source DB:  PubMed          Journal:  Acta Paediatr Scand        ISSN: 0001-656X


  6 in total

1.  Growth and growth hormone in children during and after therapy for acute lymphoblastic leukaemia.

Authors:  M Caruso-Nicoletti; M Mancuso; G Spadaro; S P Dibenedetto; A DiCataldo; G Schiliró
Journal:  Eur J Pediatr       Date:  1993-09       Impact factor: 3.183

2.  Prolonged intrathecal chemotherapy replacing cranial irradiation in high-risk acute lymphatic leukaemia: long-term follow up with cerebral computed tomography scans and endocrinological studies.

Authors:  H Hasle; J Helgestad; J K Christensen; B B Jacobsen; J Kamper
Journal:  Eur J Pediatr       Date:  1995-01       Impact factor: 3.183

3.  Longitudinal growth and final height in long-term survivors of childhood leukaemia.

Authors:  A Cicognani; E Cacciari; P Rosito; A F Mancini; G Carlă; M Mandini; G Paolucci
Journal:  Eur J Pediatr       Date:  1994-10       Impact factor: 3.183

4.  Impact of Vertebral Fractures and Glucocorticoid Exposure on Height Deficits in Children During Treatment of Leukemia.

Authors:  Jinhui Ma; Kerry Siminoski; Nathalie Alos; Jacqueline Halton; Josephine Ho; Elizabeth A Cummings; Nazih Shenouda; Mary Ann Matzinger; Brian Lentle; Jacob L Jaremko; Beverly Wilson; David Stephure; Robert Stein; Anne Marie Sbrocchi; Celia Rodd; Victor A Lewis; Caroline Laverdière; Sara Israels; Ronald M Grant; Conrad V Fernandez; David B Dix; Robert Couch; Elizabeth Cairney; Ronald Barr; Stephanie Atkinson; Sharon Abish; David Moher; Frank Rauch; Leanne M Ward
Journal:  J Clin Endocrinol Metab       Date:  2019-02-01       Impact factor: 5.958

Review 5.  Long-Term Effect of Cranial Radiotherapy on Pituitary-Hypothalamus Area in Childhood Acute Lymphoblastic Leukemia Survivors.

Authors:  Cecilia Follin; Eva Marie Erfurth
Journal:  Curr Treat Options Oncol       Date:  2016-09

6.  Growth patterns of survivors of retinoblastoma treated with ophthalmic artery chemosurgery.

Authors:  Sruti S Akella; Jasmine H Francis; Andrea Knezevic; Irina Ostrovnaya; Y Pierre Gobin; Danielle Friedman; Edith Guarini; Lindsey Eibeler; Federica Catalanotti; David H Abramson
Journal:  PLoS One       Date:  2018-05-07       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.